1. World Health Organization (WHO). Recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO October 14 1976. Acta Obstet Gynecol Scand 1977; 56: 247-253.
2. Villar J, Abalos E, Carroli G, Giordano D, Wojdyla D, Piaggio G, et al. Heterogeneity of perinatal outcomes in the preterm delivery syndrome. Obstet Gynecol 2004; 104: 78-87. [
DOI:10.1097/01.AOG.0000130837.57743.7b]
3. Steer P. The epidemiology of preterm labour. BJOG 2005; 112 (Suppl.): 1-3. [
DOI:10.1111/j.1471-0528.2005.00575.x]
4. Wen SW, Smith G, Yang Q, Walker M. Epidemiology of pretermbirth and neonatal outcome. Semin Fetal Neonatal Med 2004; 9: 429-435. [
DOI:10.1016/j.siny.2004.04.002]
5. Laws PJ, Graylon N, Sullivan EA. Australia's mothers and babies 2004.Sydney: Australian Institute of Health and Welfare, National Perinatal Statistics Unit; 2006.
6. Blondel B, Macfarlane A, Gissler M, Breart G, Zeitlin J, Groupft PS. Preterm birth and multiple pregnancy in European countries participating in the PERISTAT project. BJOG 2006; 113: 528-535. [
DOI:10.1111/j.1471-0528.2006.00923.x]
7. Gyamfi C, Horton AL, Momirova V, Rouse DJ, Caritis SN, Peaceman AM, et al. The effect of 17-alpha hydroxyl-progesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies. Am J Obstet Gynecol 2009; 201: 392. [
DOI:10.1016/j.ajog.2009.06.036]
8. Smith GC, Shah I, Pell JP, Crossley JA, Dobbie R. Maternal obesity inearly pregnancy and risk of spontaneous and elective preterm deliveries: a retrospective cohort study. Am J Public Health 2007; 97: 157-162. [
DOI:10.2105/AJPH.2005.074294]
9. Burguet A, Kaminski M, Abraham-Lerat L, Schaal JP, Cambonie G, Fresson J, et al. The complex relationship between smoking in pregnancy and very preterm delivery. Results of the Epipage study. BJOG 2004; 111: 258-265. [
DOI:10.1046/j.1471-0528.2003.00037.x]
10. Williams Obstetrics. 23th Ed. Mc graw hill publication; 2010: 805-810.
11. Buck GM, Msall ME, Schisterman EF, Lyon NR, Rogers BT. Extreme prematurity and school outcomes. Paediatr Perinat Epidemiol 2000; 14: 324-331. [
DOI:10.1046/j.1365-3016.2000.00276.x]
12. Berek and Novak's Gynecology. 15th Ed. Lippincott Williams and wilkins a wolters kluwer business, 2012:1206-1207.
13. Challis JR, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocrin Rev 2000; 21: 514-550. [
DOI:10.1210/er.21.5.514]
14. Astle S, Slater DM, Thornton S. The involvement of progesterone in the onset of human labour. Eur J Obstet Gynecol Reprod Biol 2003; 108: 177-181. [
DOI:10.1016/S0301-2115(02)00422-0]
15. Levine L. Habitual abortion. A controlled clinical study of progestational therapy. West J Surg Obstet Gynecol 1964; 72: 30-36.
16. Dodd JM, Crowther CA. The role of progesterone in prevention of preterm birth. Int J Womens Health 2010; 1: 73-84.
17. Wisborg K, Ingerslev HJ, Henriksen TB. In vitro fertilization and preterm delivery, low birth weight, and admission to the neonatal intensive care unit: a prospective follow-up study. Fertil Steril 2010; 94: 2102-2106. [
DOI:10.1016/j.fertnstert.2010.01.014]
18. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. National Institute of Child Health and Human Development Maternal- Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17α-hydroxy progesterone caproate. N Engl J Med 2003; 348: 2379-2385. [
DOI:10.1056/NEJMoa035140]
19. Mackenzie R, Walker M, Armson A, Hannah ME. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2006; 194: 1234-1242. [
DOI:10.1016/j.ajog.2005.06.049]
20. Stokes TA, Holston A, Olsen C, Choi Y, Curtis J, Higginson J, et al. Preterm Infants of Lower Gestational Age at Birth Have Greater Waist Circumference-Length Ratio and Ponderal Index at Term Age than Preterm Infants of Higher Gestational Ages. J Pediatr 2012; 161: 735-741. [
DOI:10.1016/j.jpeds.2012.03.023]
21. Bahadori F, Borna S, Shakouienejad S, Sahabi N. [Progesterone and the latency period: threatened preterm labor]. Tehran Univ Med J 2008; 66: 237-241. (In Persian)
22. Lucas B, Poole-Yaeger A, Istwan N, Stanziano G, Rhea D, Mason M. Pregnancy Outcomes of Managed Medicaid Members Prescribed Home Administration of 17α-Hydroxy progesterone Caproate. Am J Perinatol 2012; 29: 489-496.
23. Wisborg K, Ingersleve HJ, Brink Henrikson T. IVF and pereterm delivery, Low birth Weigh and admission to the neonatal ICU Caprospectno follow upoy. Fertil Steril 2010; 94: 2102-2106. [
DOI:10.1016/j.fertnstert.2010.01.014]
24. Mason MV, Poole-Yaeger A, Krueger CR, House KM, Lucas B. Impact of usage of NICU admission in a managed medicaid population-afive-year review. Manag care 2010; 19: 46-52.
25. Waters TP, Schultz BA, Mercer BM, Catalano PM. Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy. Obstet Gynecol 2009; 114: 45-49. [
DOI:10.1097/AOG.0b013e3181a9454b]